These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 6395951

  • 1. Plasma concentrations of 4-hydroxycyclophosphamide and phosphoramide mustard in patients repeatedly given high doses of cyclophosphamide in preparation for bone marrow transplantation.
    Sladek NE, Doeden D, Powers JF, Krivit W.
    Cancer Treat Rep; 1984 Oct; 68(10):1247-54. PubMed ID: 6395951
    [Abstract] [Full Text] [Related]

  • 2. Half-life of oxazaphosphorines in biological fluids.
    Sladek NE, Powers JF, Grage GM.
    Drug Metab Dispos; 1984 Oct; 12(5):553-9. PubMed ID: 6149904
    [Abstract] [Full Text] [Related]

  • 3. Nonlinear pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide/aldophosphamide in patients with metastatic breast cancer receiving high-dose chemotherapy followed by autologous bone marrow transplantation.
    Chen TL, Kennedy MJ, Anderson LW, Kiraly SB, Black KC, Colvin OM, Grochow LB.
    Drug Metab Dispos; 1997 May; 25(5):544-51. PubMed ID: 9152592
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Conversion of 4-hydroperoxycyclophosphamide and 4-hydroxycyclophosphamide to phosphoramide mustard and acrolein mediated by bifunctional catalysis.
    Low JE, Borch RF, Sladek NE.
    Cancer Res; 1982 Mar; 42(3):830-7. PubMed ID: 7059981
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. PLasma half-life and urinary excretion of cyclophosphamide in children.
    Sladek NE, Priest J, Doeden D, Mirocha CJ, Pathre S, Krivit W.
    Cancer Treat Rep; 1980 Mar; 64(10-11):1061-6. PubMed ID: 7459891
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Involvement of human glutathione S-transferase isoenzymes in the conjugation of cyclophosphamide metabolites with glutathione.
    Dirven HA, van Ommen B, van Bladeren PJ.
    Cancer Res; 1994 Dec 01; 54(23):6215-20. PubMed ID: 7954469
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Population pharmacokinetics of cyclophosphamide and its metabolites 4-hydroxycyclophosphamide, 2-dechloroethylcyclophosphamide, and phosphoramide mustard in a high-dose combination with Thiotepa and Carboplatin.
    de Jonge ME, Huitema AD, van Dam SM, Rodenhuis S, Beijnen JH.
    Ther Drug Monit; 2005 Dec 01; 27(6):756-65. PubMed ID: 16306851
    [Abstract] [Full Text] [Related]

  • 18. Thermodynamic analysis of the reaction of phosphoramide mustard with protector thiols.
    Seitz DE, Katterjohn CJ, Rinzel SM, Pearce HL.
    Cancer Res; 1989 Jul 01; 49(13):3525-8. PubMed ID: 2499418
    [Abstract] [Full Text] [Related]

  • 19. Effects of phosphoramide mustard and acrolein, cytotoxic metabolites of cyclophosphamide, on mouse limb development in vitro.
    Hales BF.
    Teratology; 1989 Jul 01; 40(1):11-20. PubMed ID: 2763206
    [Abstract] [Full Text] [Related]

  • 20. Vomiting induced by cyclophosphamide and phosphoramide mustard in cats.
    Fetting JH, McCarthy LE, Borison HL, Colvin M.
    Cancer Treat Rep; 1982 Aug 01; 66(8):1625-9. PubMed ID: 7105052
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.